Work

Biologic Precision Dosing Is Now Available at the Bedside for Children and Adults With Inflammatory Bowel Disease Receiving Infliximab

Year: 2022

Type: article

Source: Gastroenterology

DOI: 10.1053/j.gastro.2021.12.206

Authors: Phillip Minar, Abigail Samuels, Tomoyuki Mizuno, Frank Menke, Aaron Vogt, Nieko Punt, Alexander Vinks

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4206774563

FWCI:

Cites:

Cited by:

Related to: 10